Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Marimed (MRMD) over the last 10 years, with Q3 2025 value amounting to -$1.8 million.

  • Marimed's Non Operating Income fell 601.19% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.1 million, marking a year-over-year increase of 5849.0%. This contributed to the annual value of -$6.9 million for FY2024, which is 6720.84% up from last year.
  • According to the latest figures from Q3 2025, Marimed's Non Operating Income is -$1.8 million, which was down 601.19% from -$1.7 million recorded in Q2 2025.
  • Over the past 5 years, Marimed's Non Operating Income peaked at $1.0 million during Q1 2022, and registered a low of -$12.0 million during Q4 2023.
  • Moreover, its 5-year median value for Non Operating Income was -$1.7 million (2024), whereas its average is -$1.9 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 16574.8% in 2022, then crashed by 350508.98% in 2023.
  • Marimed's Non Operating Income (Quarter) stood at -$435000.0 in 2021, then grew by 23.22% to -$334000.0 in 2022, then plummeted by 3505.09% to -$12.0 million in 2023, then surged by 84.65% to -$1.8 million in 2024, then increased by 3.63% to -$1.8 million in 2025.
  • Its Non Operating Income stands at -$1.8 million for Q3 2025, versus -$1.7 million for Q2 2025 and -$1.7 million for Q1 2025.